Understanding How Cells Control Energy and Signals Through Mitochondria
Mitochondrial Calcium Uniporter in Signaling and Dynamics
This research explores how tiny parts of our cells, called mitochondria, manage calcium to control cell energy and communication, especially in conditions like cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11166366 on NIH RePORTER |
What this research studies
Our cells rely on mitochondria to manage calcium, which is vital for energy and how cells talk to each other. A special channel, the calcium uniporter (mtCU), helps calcium enter mitochondria, and its activity is fine-tuned by proteins called MICUs. When MICU proteins don't work correctly, it can lead to serious health problems, including certain human diseases and potentially contributing to conditions like cancer. This project aims to understand how these MICU proteins organize calcium signals and affect the structure and function of cells and tissues. We are looking into how MICU levels vary within and between cells, which could explain how different cells specialize in complex organs.
Who could benefit from this research
Good fit: Patients with conditions like cancer or rare diseases linked to mitochondrial calcium regulation may eventually benefit from the insights gained from this fundamental research.
Not a fit: Patients seeking immediate new treatments or direct clinical interventions will not find direct benefit from this basic science project.
Why it matters
Potential benefit: If successful, this work could uncover new ways to target cellular processes in diseases like cancer by understanding how mitochondria handle calcium.
How similar studies have performed: While the broad relevance of MICU proteins to diseases is emerging, this specific investigation into their detailed contribution to calcium signaling and cell organization is still largely undetermined.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Hajnoczky, Gyorgy — Thomas Jefferson University
- Study coordinator: Hajnoczky, Gyorgy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.